You are here

LentiGlobin BB305

Here's Why Bluebird Bio Turned in a Disappointing 2015

Motley Fool

Sat, 01/9/16 - 10:40 am

LentiGlobin BB305

Bluebird bio builds its case for gene therapy as first sickle cell patient responds

Fierce Biotech

Sat, 06/13/15 - 09:42 am

sickle cell disease

LentiGlobin BB305

Bluebird beats a path to early approval for its pioneering gene therapy

Fierce Biotech

Tue, 05/19/15 - 10:43 am

LentiGlobin BB305

Could These Experimental Drugs Eclipse Harvoni's Historic Launch?

Motley Fool

Mon, 03/30/15 - 11:13 am

LentiGlobin BB305

Gilead Sciences

Gene therapy pioneer Bluebird bags a 'breakthrough' title for lead program

Fierce Biotech

Mon, 02/2/15 - 08:08 am

beta-thalassemia

LentiGlobin BB305